52 assets in Angioimmunoblastic T-Cell Lymphoma
Therapeutic assets addressing Angioimmunoblastic T-Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Ro-Choep-21 Angioimmunoblastic T-Cell Lymphoma | Fondazione Italiana Linfomi - ETS | P1/2 | NR () |
Showing 51 to 52 of 52 assets